Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Tyra Bioscience ( (TYRA) ) is now available.
On March 4, 2026, Tyra Biosciences, Inc. agreed to issue and sell 4,000,000 shares of its common stock to a large investment management firm at $31.50 per share, in a block transaction under its existing at-the-market equity offering program. The transaction is expected to generate $126 million in gross proceeds before fees and expenses, underscoring the company’s ability to tap institutional capital and potentially strengthening its balance sheet for future operational and strategic priorities.
The shares are being issued pursuant to a previously filed shelf registration statement and accompanying sales agreement prospectus that govern the at-the-market program. By executing a sizable single-investor block sale within this framework, Tyra demonstrates continued access to public equity markets, which may influence investor perception of its funding runway and financial flexibility.
The most recent analyst rating on (TYRA) stock is a Buy with a $42.00 price target. To see the full list of analyst forecasts on Tyra Bioscience stock, see the TYRA Stock Forecast page.
Spark’s Take on TYRA Stock
According to Spark, TipRanks’ AI Analyst, TYRA is a Neutral.
The score is held back mainly by weak financial performance (no revenue, widening losses, and rising cash burn despite low leverage). Technicals provide the primary support, with price trading above key moving averages and positive momentum indicators. Valuation contributes little due to the negative P/E and no dividend yield data.
To see Spark’s full report on TYRA stock, click here.
More about Tyra Bioscience
Tyra Biosciences, Inc. is a biotechnology company that issues common stock under an at-the-market offering program registered with the U.S. Securities and Exchange Commission. The company accesses capital markets through block transactions with institutional investors to support its corporate and operational needs within the life sciences sector.
Average Trading Volume: 679,092
Technical Sentiment Signal: Buy
Current Market Cap: $1.78B
See more data about TYRA stock on TipRanks’ Stock Analysis page.